SciDev (SDV.AX) Stock Price
SciDev Price
SciDev (SDV.AX) — ISIN AU000000SDV5. The SciDev stock price was 0.23 AUD in 2026. Revenue was 128.67 M AUD. Earnings were 4.41 M AUD. P/E ratio was 9.69. SciDev operates in the Commodities sector.
SciDev stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of SciDev over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how SciDev stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing SciDev's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | SciDev Price |
|---|---|
| 2/26/2026 | 0.23 AUD |
| 2/25/2026 | 0.24 AUD |
| 2/24/2026 | 0.35 AUD |
| 2/23/2026 | 0.35 AUD |
| 2/20/2026 | 0.35 AUD |
| 2/19/2026 | 0.36 AUD |
| 2/18/2026 | 0.37 AUD |
| 2/17/2026 | 0.36 AUD |
| 2/16/2026 | 0.37 AUD |
| 2/13/2026 | 0.36 AUD |
| 2/12/2026 | 0.39 AUD |
| 2/11/2026 | 0.37 AUD |
| 2/10/2026 | 0.39 AUD |
| 2/9/2026 | 0.37 AUD |
| 2/6/2026 | 0.38 AUD |
| 2/5/2026 | 0.39 AUD |
| 2/4/2026 | 0.38 AUD |
| 2/3/2026 | 0.38 AUD |
| 2/2/2026 | 0.38 AUD |
SciDev Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
SciDev Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M AUD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M AUD) |
| NET INCOME (M AUD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 9 | 27 | 1 | 0 | 8 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 18 | 42 | 55 | 89 | 109 | 103 | 128 | 141 |
| – | 100.00 | – | – | – | – | – | 100.00 | 50.00 | 200.00 | 200.00 | -96.30 | – | – | -75.00 | -50.00 | – | – | – | – | 100.00 | – | 800.00 | 133.33 | 30.95 | 61.82 | 22.47 | -5.50 | 24.27 | 10.16 |
| 3,400.00 | 1,700.00 | – | – | – | – | 3,400.00 | 1,700.00 | 1,133.33 | 11.11 | 37.04 | 3,400.00 | – | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 3,400.00 | 1,700.00 | 1,700.00 | 16.67 | 23.81 | 30.91 | 26.97 | 30.28 | 33.01 | 26.56 | 24.11 |
| 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 1 | 10 | 34 | 34 | 8 | 2 | 1 | 1 | 1 | 1 | 34 | 34 | 34 | 3 | 10 | 17 | 24 | 33 | 34 | 34 | 34 |
| 0 | -5 | -3 | 0 | -3 | -3 | -2 | -3 | -4 | -1 | -2 | -21 | -1 | 1 | -3 | -2 | -1 | 0 | 0 | 0 | 1 | -2 | 0 | 3 | 0 | 0 | 2 | 0 | 4 | 6 |
| – | – | -40.00 | – | – | – | -33.33 | 50.00 | 33.33 | -75.00 | 100.00 | 950.00 | -95.24 | -200.00 | -400.00 | -33.33 | -50.00 | – | – | – | – | -300.00 | – | – | – | – | – | – | – | 50.00 |
| 0.62 | 0.62 | 0.62 | 0.62 | 1.35 | 1.63 | 2.48 | 3.9 | 4.9 | 6.14 | 5.92 | 7.28 | 9.65 | 20.01 | 26.15 | 32.26 | 32.26 | 32.26 | 32.26 | 41.59 | 53.29 | 75.68 | 127.53 | 154.75 | 177.37 | 189.68 | 189.85 | 189.98 | 189.98 | 189.98 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales SciDev generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue SciDev retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare SciDev's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares SciDev has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against SciDev's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Unlock the full history with 30+ years of data and forecast estimates.
Unlock all data — PROSciDev Stock Quarterly Figures
| REVENUE (M AUD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M AUD) |
| NET INCOME (M AUD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| 2001 Q2 | 2001 Q4 | 2002 Q2 | 2002 Q4 | 2003 Q2 | 2003 Q4 | 2004 Q2 | 2004 Q4 | 2005 Q2 | 2005 Q4 | 2006 Q2 | 2006 Q4 | 2007 Q2 | 2007 Q4 | 2008 Q2 | 2008 Q4 | 2009 Q2 | 2009 Q4 | 2010 Q2 | 2010 Q4 | 2011 Q2 | 2011 Q4 | 2012 Q2 | 2012 Q4 | 2013 Q2 | 2013 Q4 | 2014 Q2 | 2014 Q4 | 2015 Q2 | 2015 Q4 | 2016 Q2 | 2016 Q4 | 2017 Q2 | 2017 Q4 | 2018 Q2 | 2018 Q4 | 2019 Q2 | 2019 Q4 | 2020 Q2 | 2020 Q4 | 2021 Q2 | 2021 Q4 | 2022 Q2 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q2 | 2024 Q4 | 2025 Q2 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 | 11 | 18 | 24 | 24 | 31 | 24 | 49 | 20 | 40 | 50 | 58 | 49 | 53 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 500.00 | 83.33 | 63.64 | 33.33 | – | 29.17 | -22.58 | 104.17 | -59.18 | 100.00 | 25.00 | 16.00 | -15.52 | 8.16 |
| – | – | – | – | – | – | – | 1,700.00 | – | – | – | 66.67 | – | 33.33 | – | – | – | – | – | – | – | 66.67 | – | 100.00 | – | – | – | – | – | – | – | – | – | – | 1,700.00 | 1,700.00 | 1,700.00 | 1,700.00 | 16.67 | 9.09 | 22.22 | 20.83 | 25.00 | 32.26 | 20.83 | 24.49 | 25.00 | 27.50 | 28.00 | 31.03 | 32.65 | 32.08 |
| 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | -1 | -2 | 2 | -2 | 3 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 2 | 17 | 2 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 1 | 1 | 4 | 5 | 6 | 10 | 5 | 12 | 5 | 11 | 14 | 18 | 16 | 17 |
| 0 | 0 | -2 | -1 | -1 | -1 | 0 | -1 | -2 | -1 | -5 | 0 | -5 | 4 | 1 | -4 | -19 | -1 | 0 | -2 | 2 | -1 | -3 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 3 | -1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| – | – | – | -50.00 | – | – | – | – | 100.00 | -50.00 | 400.00 | – | – | -180.00 | -75.00 | -500.00 | 375.00 | -94.74 | – | – | -200.00 | -150.00 | 200.00 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -133.33 | -200.00 | – | – | – | – | – | – | – | – |
| 0.47 | 0.77 | 1.25 | 1.46 | 1.63 | 1.63 | 2.21 | 2.74 | 3.07 | 4.74 | 4.79 | 5.01 | 6.01 | 5.81 | 6.22 | 5.92 | 7.23 | 7.28 | 10.08 | 4.48 | 16.43 | 23.19 | 22.96 | 29.34 | 34.51 | 30.01 | 32.81 | 31.71 | 30.34 | 34.18 | 34.1 | 30.42 | 35.95 | 47.22 | 53.25 | 53.33 | 67.04 | 84.32 | 118.07 | 137 | 150.54 | 158.96 | 167.81 | 186.92 | 189.52 | 189.52 | 189.85 | 189.85 | 189.85 | 189.85 | 189.92 | 190.05 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales SciDev generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue SciDev retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare SciDev's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares SciDev has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against SciDev's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Unlock the full history with 30+ years of data and forecast estimates.
Unlock all data — PROSciDev stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
SciDev Stock Sales Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
SciDev business model
SciDev SWOT Analysis
Strengths
Scidev Ltd possesses the following strengths:
- Strong market reputation and brand recognition.
- Advanced technological infrastructure and software solutions.
- Highly skilled and experienced team of professionals.
- Established partnerships with key industry players.
- Efficient and streamlined internal processes.
- Robust financial position and steady revenue growth.
Weaknesses
Scidev Ltd faces the following weaknesses:
- Limited product diversification.
- Relatively small market share compared to competitors.
- Dependency on a specific customer segment.
- Lack of global presence and market penetration.
- Challenges in adapting to rapidly changing technology trends.
- Potential vulnerabilities in data security and privacy.
Opportunities
Scidev Ltd should consider the following opportunities:
- Growing market demand for advanced software solutions.
- Expansion into new geographical markets.
- Development of strategic partnerships with complementary businesses.
- Integration of emerging technologies to enhance product offerings.
- Leveraging data analytics to drive customer insights and innovation.
Threats
Scidev Ltd should be cautious of the following threats:
- Intense competition and price pressures from rival firms.
- Rapid technological advancements leading to product obsolescence.
- Regulatory changes impacting industry operations and compliance.
- Economic downturns affecting customer spending and budget cuts.
- Intellectual property infringement and unauthorized data access.
SciDev Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
SciDev historical P/E ratio, EBIT multiple, and P/S ratio
SciDev shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
SciDev stock splits
Current SciDev forecasts and price targets in March 2026
| Δ MOM Price Target | null % |
| Buy | 80.00 % (4) |
| Hold | 20.00 % (1) |
| Sell | null % (0) |
| 12M Price Target | 0.61 |
| Last Price | 0.18 |
| Currency | AUD |
| 12M Return Potential | 236.26 % |
| LTM Return | 0 % |
SciDev Earnings Estimates
SciDev Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 9/1/2022 | 0.01AUD | 31.77 MAUD | 2022 Q4 |
| 2/21/2022 | -0AUD | 24.46 MAUD | 2022 Q2 |
| 8/31/2021 | 0.01AUD | 24.66 MAUD | 2021 Q4 |
| 2/8/2021 | 0.3AUD | 19.69 MAUD | 2021 Q2 |
| 9/1/2008 | 0AUD | 14.21 MAUD | 2008 Q4 |
SciDev shareholders
| % | Name |
|---|---|
15.15574% | |
8.68183% | |
4.07933% | |
3.21083% | |
2.98655% | |
2.63224% | |
2.10546% | |
2.10546% | |
1.18432% | |
1.13755% |
SciDev Executives and Management Board
Mr. Sean Halpin
Chief Executive Officer
Ms. Anna Hooper
Chief Financial Officer
Mr. Heath Roberts
Company Secretary
Mr. Vaughan Busby
Non-Executive Independent Chairman of the Board
Mr. Dan O ' Toole
Non-Executive Director
SciDev Research
SoonDeep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.
Research reports are coming soon
We're building institutional-grade equity research for SciDev and thousands of other companies.
Most common questions regarding SciDev
The business model of Scidev Ltd revolves around providing advanced scientific research equipment and solutions to support the development and advancements in the scientific field. Scidev Ltd offers a wide range of specialized products, including laboratory instruments, scientific software, and consumables, catering to the needs of various research institutions, universities, and industries. By collaborating with leading manufacturers and providing exceptional customer service, Scidev Ltd establishes itself as a reliable and trusted partner for scientific communities. The company's dedication to offering innovative and high-quality products contributes to the growth and success of the scientific industry.
SciDev stock
SciDev Peer Group
SciDev Ticker
SciDev FIGI
All fundamentals about SciDev
Our stock analysis for SciDev Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SciDev Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.